• EN
Search

General Population Surveys annual expert meeting, 17-18 June 2014, Lisbon

 

 

General Population Surveys annual expert meeting, 17–18 June 2014, Lisbon

street scene at a café

On 17 and 18 June 2014, the EMCDDA brought together forty-five European and international experts for a meeting on the key indicator Prevalence and patterns of drug use among the general population (GPS) (*). Ten EMCDDA staff members also participated in different parts of the meeting. There were presentations from both EU and other countries, projects and institutions (Balkan countries, Israel, the ESPAD project, Eurostat, the SMART and RARHA projects on alcohol).

These regular meetings on the indicator change their focus from year to year. This year particular attention was given to cannabis and alcohol, in addition to new psychoactive substances (NPS) and psychoactive medicines.

Regarding cannabis, a multi-indicator analysis (prevalence, supply, consequences, treatment) was presented, and the monitoring of high risk cannabis use was analysed. Monitoring cannabis use, high risk cannabis use and resulting problems are currently top level policy issues, given the ongoing, rapid changes in cannabis regulation.

The EMCDDA — together with many experts — has developed guidelines to be released shortly which aim to improve the accuracy of estimations of high risk cannabis use using psychometric scales (in particular CAST). Prevention and interventions (when needed) around cannabis were not addressed in this year’s meeting, but they will be addressed in future meetings, as well as issues on cannabis markets and potency.

Attention was also given to instruments to measure alcohol use. EMCDDA is working closely with the RARHA Joint Action (Joint Action on Reducing Alcohol Related Harm) of the Health and Food Safety Directorate General (DG SANTE) of the European Commission to develop common instruments to measure alcohol use and problems. Attention was given to the monitoring of new psychoactive substances and psychoactive medicines. The EMCDDA has developed a module on NPS to be used on population surveys similar to the one used in ESPAD and the Eurobarometer, but some countries are still using different instruments. Measurement of psychoactive medicine use is particularly challenging, both because of their availability in the legal, illegal and grey markets (e.g. on-line pharmacies), and because differentiation between use and abuse could be very subjective in many cases.

Together with the agenda, list of participants and presentations, you will find a number of recently published reports or resources related to population surveys.


(*) The EMCDDA key indicators are a broad domain of knowledge that address drug demand (prevalence and patterns of use in general populationprevalence and patterns of problem drug use, and treatment demand indicator (TDI)) and drug problems (drug-related deaths (DRD) and drug-related infectious diseases)

Final Minute GPS Meeting 2014
Download this attachment in DOC format
Final Brief summary GPS Meeting 2014
Download this attachment in DOC format
Participants_list_contacts_2014
Download this attachment in PDF format
National Abstract 2014 - Compilation
Download this attachment in PDF format
Julian Vicente - Prevalence and patterns update and main developments in GPS 2014
Download this attachment in PDF format
Bjorn Hibell - Developments and progress in ESPAD
Download this attachment in PDF format
Nicola Singleton - Cannabis trends in the UK
Download this attachment in PDF format
Pavla Chomynova - Cannabis Trends in the Czech Republic
Download this attachment in PDF format
Janusz Sieroslawski - Trend in drug use in Poland
Download this attachment in PDF format
Darja Latvar - results on Tobacco in Slovenia
Download this attachment in PDF format
Richard Branstrom - Recent studies on Drug Use in Sweden
Download this attachment in PDF format
Yossi Harel-Fisch - Innovative national survey systems in Israel
Download this attachment in PDF format
Biljana Kilibarda - Drug use in Serbia
Download this attachment in PDF format
Danica Thanki - Monitoring frequent and high risk cannabis use
Download this attachment in PDF format
Linda Montanari - Profile and trends of cannabis users admitted to treatment
Download this attachment in PDF format
Roland Simon - Cannabis users inside and outside treatment
Download this attachment in PDF format
Joao Matias - Drug situation in Europe's GPS 2014
Download this attachment in PDF format
Jakub Hrkal - European Health Interview Survey (EHIS)
Download this attachment in PDF format
Andre Noor - Estimating drug market size
Download this attachment in PDF format
Biljana Kilibarda - SMART questionnaire in Serbia
Download this attachment in PDF format
Darja Lavtar - SMART survey on Alcohol in Slovenia
Download this attachment in PDF format
Marcis Trapencieris - SMART alcohol questionnaire in Latvia
Download this attachment in PDF format
Bjorn Hibell - A test of the EMQ module about NPS
Download this attachment in PDF format
Darja Latvar - Results on new drugs in Slovenia
Download this attachment in PDF format
Klaudia Palczak - Monitoring misuse of psychoactive medicines at the EMCDDA
Download this attachment in PDF format
Momtchil Vassilev - Developments and progress in medicines use in Bulgaria
Download this attachment in PDF format
Ildze Redovica - Misuse of benzodiazepines in Latvia
Download this attachment in PDF format
Dijana Jerkovic - Insight into the pharmaceuticals use in Croatia
Download this attachment in PDF format

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Friday, 10 July 2015